1,177
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia

, , &
Pages 1828-1835 | Received 13 Feb 2015, Accepted 03 May 2015, Published online: 06 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yu Hu, Xuejiao Pan, Fuxing Chen, Ying Wang, Hui Liang, Linzhi Shen, Yaping Chen & Huakun Lv. (2022) Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China. Human Vaccines & Immunotherapeutics 18:1.
Read now
Francisca Aguirre-Boza, Pamela San Martín P & María Teresa Valenzuela B. (2021) How were DTP-related adverse events reduced after the introduction of an acellular pertussis vaccine in Chile?. Human Vaccines & Immunotherapeutics 17:11, pages 4225-4234.
Read now

Articles from other publishers (4)

Yi-hong Ni, Zhen-hui Xu & Jing Wang. (2023) Understanding vaccine hesitancy with PCV13 in children: Results of a survey in Shanghai, China. PLOS ONE 18:4, pages e0284810.
Crossref
Piyameth Dilokthornsakul, Kirati Kengkla, Surasak Saokaew, Unchalee Permsuwan, Chonnamet Techasaensiri, Tawee Chotpitayasunondh & Nathorn Chaiyakunapruk. (2019) An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand. Vaccine 37:32, pages 4551-4560.
Crossref
Hazel J. Clothier, Nigel W. Crawford, Melissa Russell, Heath Kelly & Jim P. Buttery. (2017) Evaluation of ‘SAEFVIC’, A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia. Drug Safety 40:6, pages 483-495.
Crossref
. (2015) Pneumococcal 13-valent CRM197 vaccine conjugate/pneumococcal 7-valent CRM197 vaccine conjugate. Reactions Weekly 1577:1, pages 206-206.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.